Stock DNA
Chemicals & Petrochemicals
CNY 2,198 Million (Small Cap)
27.00
NA
0.92%
-0.02
7.52%
2.03
Revenue and Profits:
Net Sales:
248 Million
(Quarterly Results - Jun 2025)
Net Profit:
21 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.9%
0%
-16.9%
6 Months
20.77%
0%
20.77%
1 Year
39.45%
0%
39.45%
2 Years
31.01%
0%
31.01%
3 Years
30.95%
0%
30.95%
4 Years
16.57%
0%
16.57%
5 Years
-25.81%
0%
-25.81%
Zhejiang Dayang Biotech Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.90%
EBIT Growth (5y)
-1.40%
EBIT to Interest (avg)
10.37
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
0.67
Tax Ratio
10.04%
Dividend Payout Ratio
39.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.61%
ROE (avg)
7.03%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
2.03
EV to EBIT
29.94
EV to EBITDA
15.68
EV to Capital Employed
2.05
EV to Sales
2.27
PEG Ratio
0.68
Dividend Yield
0.92%
ROCE (Latest)
6.85%
ROE (Latest)
7.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
247.70
240.40
3.04%
Operating Profit (PBDIT) excl Other Income
33.00
26.50
24.53%
Interest
1.40
3.00
-53.33%
Exceptional Items
0.70
0.00
Consolidate Net Profit
21.00
14.50
44.83%
Operating Profit Margin (Excl OI)
67.30%
40.40%
2.69%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 3.04% vs 5.07% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 44.83% vs 222.22% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
902.30
912.10
-1.07%
Operating Profit (PBDIT) excl Other Income
132.70
112.40
18.06%
Interest
7.30
6.70
8.96%
Exceptional Items
-6.50
-18.50
64.86%
Consolidate Net Profit
63.70
50.00
27.40%
Operating Profit Margin (Excl OI)
70.90%
47.90%
2.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.07% vs -13.20% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 27.40% vs -38.04% in Dec 2023
About Zhejiang Dayang Biotech Group Co., Ltd. 
Zhejiang Dayang Biotech Group Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






